LIPO - Lipella Pharmaceuticals Inc
2.19
-0.060 -2.740%
Share volume: 43,248
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$2.25
-0.06
-0.03%
Summary score
28%
Profitability
0%
Dept financing
32%
Liquidity
50%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-49.99%
Return on sales
-1116.09%
Return on invested capital
0%
Total debt ratio
24.27%
Debt ratio change over timeo
0%
Current Ratio
4.25%
Quick Ratio
0%
Cash Position Ratio
2.74%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-49.99%
Return on sales
-1116.09%
Return on invested capital
0%
Total debt ratio
24.27%
Debt ratio change over timeo
0%
Current Ratio
4.25%
Quick Ratio
0%
Cash Position Ratio
2.74%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-67.56%
Return on sales
-1815.64%
Return on invested capital
0%
Total debt ratio
32.46%
Debt ratio change over time
0%
Current Ratio
2.97%
Quick Ratio
0%
Cash Position Ratio
1.93%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LIPO | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 17.26% | 0% | 0% |
| Return on assets | -49.99% | 4.16% | 0% | 0% |
| Return on sales | -1116.09% | 27.72% | 0% | 0% |
| Return on invested capital | 0% | 9.99% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 24.27% | 81.62% | 0% | 0% |
| Debt ratio change over time | 0% | -14.38% | 0% | 0% |
| Dept financing | 32% | 25% | 0% | 0% |
| Current Ratio | 4.25% | 1.16% | 0% | 0% |
| Quick Ratio | 0% | 0.89% | 0% | 0% |
| Cash Position Ratio | 2.74% | 0.12% | 0% | 0% |
| Liquididy | 50% | 34% | 0% | 0% |
| Short-term ratios | LIPO | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 18.92% | 0% | 0% |
| Return on assets | -49.99% | 3.96% | 0% | 0% |
| Return on sales | -1116.09% | 27.19% | 0% | 0% |
| Return on invested capital | 0% | 15.53% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 24.27% | 81.43% | 0% | 0% |
| Debt ratio change over time | 0% | -33.85% | 0% | 0% |
| Dept financing | 32% | 25% | 0% | 0% |
| Current Ratio | 4.25% | 1.16% | 0% | 0% |
| Quick Ratio | 0% | 0.89% | 0% | 0% |
| Cash Position Ratio | 2.74% | 0.12% | 0% | 0% |
| Liquididy | 50% | 33% | 0% | 0% |